Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Brazilian researchers reveal bactericidal action mechanism of violacein

Brazilian researchers reveal bactericidal action mechanism of violacein

In an article published in the journal ACS Infectious Diseases, Brazilian researchers describe the bactericidal action mechanism of violacein, a violet pigment produced by environmental bacteria, especially Chromobacterium violaceum.

According to the authors of the study, the substance targets the cytoplasmic membrane of bacteria, mainly affecting gram-positive bacteria such as those of the genera Streptococcus, Enterococcus and Listeria. Its various biological activities include the capacity to kill even bacteria that have become resistant to antibiotics.

The investigation was conducted with support from São Paulo Research Foundation – FAPESP by the research groups led by Frederico Gueiros-Filho at the University of São Paulo’s Chemistry Institute (IQ-USP) and Marcelo Brocchi at the University of Campinas’s Biology Institute (IB-UNICAMP).

“This pigment’s powerful bactericidal properties were discovered in 1945, yet its action mechanism has never been studied before. Many biologically active molecules are described in the literature, but if we want to use them to develop drugs, we have to know how they work,” Gueiros-Filho said.

Attractive target

Violacein is a natural pigment derived from the amino acid tryptophan. It is produced as a secondary metabolite by several phylogenetically distinct bacteria found in environments as diverse as oceans, glaciers, rivers and soil. C. violaceum is the first bacterium described as a violacein producer and the most studied to date.

Violacein has attracted attention because of its wide biological activity spectrum. In addition to its potent activity against bacteria, including drug-resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA), it has antifungal, antiprotozoal, antiviral, antitumor and antioxidant properties. Several studies describe these properties, but according to Gueiros-Filho, violacein’s target and mode of action had never before been precisely identified.

The first step of the study, he explained, consisted of treating bacteria of the species S. aureus and Bacillus subtilis with violacein. Using fluorescence microscopy and a set of indicator dyes, the group found that the pigment rapidly permeabilized the bacteria cells. Cell permeabilization was accompanied by the appearance of visible discontinuities (holes or rips) in the cytoplasmic membranes, while the cell walls remained intact.

The researchers also demonstrated membrane permeabilization by measuring the leakage of ATP (adenosine triphosphate, a key energy transport and storage molecule) in the treated cells.

Next, in collaboration with the group led by Iolanda M. Cuccovia, a professor at IQ-USP, they conducted in vitro experiments that showed violacein also disrupting the structure and permeability of liposomes, spherical vesicles with an aqueous core and a membrane created in the test tube from phospholipids, the main components of organic cell membranes.

“With these experiments, we showed that the phenomenon observed in cells could be attributed to a direct effect of violacein on the membrane,” Gueiros-Filho said.

In addition, computer simulations of molecular dynamics were used to explore how violacein interacts with lipid bilayers, such as those that form the cytoplasmic membrane.

Based on the results obtained, the authors of the study propose that the presence of violacein between the layers of phospholipids was sufficient to interfere with membrane organization, increasing the distance between phospholipid molecules and leading to loss of membrane integrity.

By damaging membranes, violacein is capable of destroying persistent bacteria that lie dormant as a strategy for resisting antibiotics that depend on the microorganism’s metabolic activity. These bacteria form biofilms to survive in hostile environments.

The cytoplasmic membrane is an attractive and underexploited target for antimicrobials, according to the researchers, for whom the discovery that violacein is a membrane-targeting compound should set the stage for future research on the usefulness of this natural product.

The research was supported by FAPESP via the projects “How do bacteria coordinate membrane biogenesis with cell growth and division?”, “Antibacterial activity of violacein against Staphylococcus aureus and pharmacokinetic studies” and “Interface chemistry: drugs, peptides and enzymes interactions with membrane models”.

A key focus for future investigation is the question of violacein’s selectivity. The cytoplasmic membrane is similar in and common to all living cells, so violacein may also be capable of disrupting eukaryotic cells such as those of humans. This property could be why it displays activity against so many types of pathogens, including fungi and protozoans as well as tumors, Gueiros-Filho said.

Preliminary results obtained by researchers at IQ-USP and IB-UNICAMP suggest that violacein is not highly selective for bacterial membranes and could become toxic to the host. If so, the molecule would have to be chemically modified to make it more specific.

The spread of multidrug-resistant bacteria due to the overuse of antibiotics in human medicine and agriculture is one of the most important current threats to public health. The World Health Organization (WHO) has warned of the imminence of a postantibiotic era in which common infections and minor injuries treatable for decades become lethal once again.

Most currently used antibiotics were discovered several decades ago and are directed against a limited set of targets, so the development of new antimicrobials with novel mechanisms of action is urgently needed.


Tagged with:

About author

Related Articles